Ars Technica on Nostr: FTC blasts drug middlemen for “inflating” costs, “squeezing” pharmacies ...
FTC blasts drug middlemen for “inflating” costs, “squeezing” pharmacies
Pharmacy benefit managers (PBMs) are key part of US's high drug costs, report finds.
https://arstechnica.com/tech-policy/2024/07/ftc-blasts-drug-middlemen-for-inflating-costs-squeezing-pharmacies/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social
Pharmacy benefit managers (PBMs) are key part of US's high drug costs, report finds.
https://arstechnica.com/tech-policy/2024/07/ftc-blasts-drug-middlemen-for-inflating-costs-squeezing-pharmacies/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social